
Reven Holdings announces first patient dosed in clinical trial evaluating RJX for high-risk COVID-19
WESTMINSTER -- Reven Holdings, Inc. today announced the first patient has been dosed in the Phase I/II trial of RJX in high-risk COVID-19 patients ( ClinicalTrials.gov Identifier: NCT04708340; ... Read More
Thursday April 29, 2021 0 comments

Ampio: Ampion reduces all-cause mortality in COVID-19 respiratory distress by nearly 80%
ENGLEWOOD -- Ampio Pharmaceuticals (NYSE American: AMPE) announced positive results in its AP-014 Phase I clinical trial utilizing inhaled Ampion in treating respiratory distress in patients as a... Read More
Wednesday April 28, 2021 0 comments

Ampio study: Ampion inhibits key inflammatory pathway in COVID-19 and lupus nephritis
ENGLEWOOD -- Ampio Pharmaceuticals (NYSE American: AMPE) announced results of a pre-clinical study demonstrating Ampion inhibits an important pro-inflammatory pathway in the types of immune cells... Read More
Friday April 9, 2021 0 comments

CU: Carbon dioxide levels reflect COVID-19 risk
BOULDER -- Tracking carbon dioxide levels indoors is an inexpensive and powerful way to monitor the risk of people getting COVID-19, according to new research from the Cooperative Institute for... Read More
Friday April 9, 2021 0 comments

Ampio Pharmaceuticals details early positive results for inhaled Ampion in COVID-19 distress
ENGLEWOOD -- Ampio Pharmaceuticals (NYSE American: AMPE) revealed preliminary positive results in its AP-014 Phase I clinical trial utilizing inhaled Ampion in treating respiratory distress in... Read More
Wednesday March 17, 2021 0 comments

Everside Health approved to administer COVID vaccine in 22 states, 10 more states pending
DENVER -- Everside Health (formerly Paladina Health, Activate Healthcare and Healthstat), announced it has been approved to administer the COVID-19 vaccine in 22 states. With pending approval in... Read More
Monday March 1, 2021 0 comments

Hach and LuminUltra partner to deliver first rapid test for SARS-CoV-2 in wastewater
LOVELAND -- Hach , a leader in water analysis, and Canada-based LuminUltra , a leader in biological diagnostic testing, have partnered to offer the world's first rapid, on-site testing solution for... Read More
Friday February 26, 2021 0 comments

CSU vaccine research advances to develop coronavirus vaccine for next pandemic
FORT COLLINS -- As scientists at Colorado State University continue their research on four coronavirus vaccine candidates, investigators are developing a plan to collaborate with scientists at other... Read More
Wednesday February 24, 2021 0 comments